The lab has been awarded a grant of 1.8 MSEK in total from The Swedish Cancer Society (swedish "Cancerfonden") to study matrix metalloproteinase triggered liposomal drug release for precision cancer therapy. The work will be conducted in collaboration with Prof. Torbjörn Bengtsson at Örebro University.